Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 44 studies | 68% ± 26% | |
pericyte | 29 studies | 41% ± 21% | |
endothelial cell of lymphatic vessel | 27 studies | 80% ± 25% | |
fibroblast | 27 studies | 34% ± 12% | |
capillary endothelial cell | 17 studies | 74% ± 19% | |
endothelial cell of artery | 16 studies | 64% ± 21% | |
smooth muscle cell | 15 studies | 29% ± 14% | |
vein endothelial cell | 14 studies | 69% ± 21% | |
connective tissue cell | 13 studies | 32% ± 9% | |
endothelial cell of vascular tree | 13 studies | 70% ± 22% | |
platelet | 11 studies | 72% ± 25% | |
myofibroblast cell | 8 studies | 26% ± 10% | |
megakaryocyte | 6 studies | 71% ± 17% | |
mesothelial cell | 6 studies | 37% ± 9% | |
ionocyte | 4 studies | 24% ± 3% | |
glomerular endothelial cell | 4 studies | 89% ± 5% | |
retinal pigment epithelial cell | 4 studies | 46% ± 20% | |
adventitial cell | 4 studies | 36% ± 5% | |
endothelial cell of sinusoid | 4 studies | 56% ± 33% | |
epithelial cell of proximal tubule | 3 studies | 32% ± 12% | |
pro-B cell | 3 studies | 39% ± 11% | |
epithelial cell | 3 studies | 44% ± 28% | |
lymphocyte | 3 studies | 67% ± 31% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3320.15 | 89 / 89 | 99% | 114.79 | 888 / 901 |
thymus | 100% | 4597.42 | 652 / 653 | 97% | 46.58 | 588 / 605 |
adrenal gland | 99% | 2313.41 | 255 / 258 | 96% | 103.29 | 221 / 230 |
breast | 100% | 9516.63 | 459 / 459 | 93% | 28.84 | 1043 / 1118 |
prostate | 99% | 2442.04 | 242 / 245 | 88% | 18.50 | 442 / 502 |
lung | 100% | 5877.54 | 577 / 578 | 83% | 26.72 | 957 / 1155 |
bladder | 100% | 4068.76 | 21 / 21 | 69% | 17.28 | 346 / 504 |
brain | 71% | 1083.32 | 1871 / 2642 | 96% | 27.22 | 674 / 705 |
ovary | 100% | 7808.03 | 180 / 180 | 65% | 13.19 | 281 / 430 |
skin | 86% | 2834.62 | 1558 / 1809 | 78% | 46.14 | 369 / 472 |
uterus | 99% | 4903.58 | 169 / 170 | 55% | 17.87 | 253 / 459 |
intestine | 92% | 2819.31 | 891 / 966 | 61% | 13.04 | 322 / 527 |
stomach | 78% | 1842.31 | 279 / 359 | 72% | 14.92 | 206 / 286 |
esophagus | 88% | 2751.32 | 1272 / 1445 | 58% | 9.85 | 107 / 183 |
pancreas | 33% | 391.66 | 107 / 328 | 97% | 35.52 | 172 / 178 |
liver | 35% | 443.27 | 80 / 226 | 85% | 18.37 | 345 / 406 |
adipose | 100% | 10428.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 5651.79 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 3391.85 | 859 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 120.14 | 79 / 80 |
blood vessel | 98% | 2771.43 | 1304 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 22.35 | 24 / 29 |
muscle | 69% | 947.50 | 555 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 56% | 7.73 | 25 / 45 |
peripheral blood | 26% | 365.92 | 239 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0005834 | Cellular component | heterotrimeric G-protein complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0031681 | Molecular function | G-protein beta-subunit binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | GNG11 |
Protein name | Guanine nucleotide-binding protein subunit gamma Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 |
Synonyms | hCG_19197 GNGT11 tcag7.247 |
Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. . |
Accessions | P61952 ENST00000248564.6 Q53Y01 |